Ven Bio Partners LLC Alx Oncology Holdings Inc Transaction History
Ven Bio Partners LLC
- $122 Million
- Q3 2024
A detailed history of Ven Bio Partners LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Ven Bio Partners LLC holds 9,699,925 shares of ALXO stock, worth $14.9 Million. This represents 14.51% of its overall portfolio holdings.
Number of Shares
9,699,925
Previous 9,699,925
-0.0%
Holding current value
$14.9 Million
Previous $58.5 Million
69.82%
% of portfolio
14.51%
Previous 33.06%
Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
101Shares Held
39.7MCall Options Held
134KPut Options Held
17.4K-
Tang Capital Management LLC San Diego, CA4.2MShares$6.48 Million0.65% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.03MShares$6.21 Million1.07% of portfolio
-
Redmile Group, LLC San Francisco, CA3.84MShares$5.91 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.14 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$3.71 Million0.68% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $62.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...